补充因子D在急性髓性白血病中的临床意义和潜在功能
Taigang Zhang1, Zhaozhong Li2, Aoyu He2
1Department of Clinical Laboratory, The Affiliated People's Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou, CHN.
Cureus
|September 23, 2024
概括
补充因子D (CFD) 在急性髓性白血病 (AML) 中表达高,表明整体存活率更好. 高CFD表达可能作为AML患者的预后生物标志物,指导临床治疗策略.
科学领域:
- 血液学恶性瘤是什么
- 癌症基因组学 癌症基因组学
- 免疫学 免疫学 免疫学
背景情况:
- 急性髓性白血病 (AML) 是一种具有不良预后的侵袭性血液癌症.
- 识别可靠的预后标志物对于有效的AML管理至关重要.
- 补充因子D (CFD) 在AML中的作用需要进一步阐明.
研究的目的:
- 调查CFD在AML中的临床意义和功能作用.
- 确定CFD是否可以作为AML患者的预后生物标志物.
- 探索CFD与AML治疗敏感性和免疫透的关联.
主要方法:
- 使用了多个公共数据库,包括TCGA,GEO,HPA,UALCAN,GEPIA,CCLE和CAMOIP.
- 在AML细胞和患者队伍中分析了CFD表达.
- 使用RT-qPCR验证的CFD表达式.
- 为整体生存预测构建了一个名ogram模型.
主要成果:
- 与正常对照组相比,CFD表达在AML细胞和患者中显著更高.
- 在AML中,高CFD表达与更好的整体存活率 (OS) 和较低的瘤突变负担 (TMB) 相相关.
- 在AML中,CFD表达与药物敏感性和单细胞透有关.
结论:
- CFD是AML整体存活率的潜在预后生物标志物.
- CFD表达水平可以指导AML患者的临床治疗决策.
- 对CFD作用的进一步研究可以改善AML治疗策略.
相关概念视频
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
Role of Hematopoietic Growth Factors
1.3K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.3K
Disorders of Leukocytes
903
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
903
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K


